These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25275293)

  • 1. Risk for uveitis with oral moxifloxacin: a comparative safety study.
    Eadie B; Etminan M; Mikelberg FS
    JAMA Ophthalmol; 2015 Jan; 133(1):81-4. PubMed ID: 25275293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of severe dysglycemia among diabetic patients receiving levofloxacin, ciprofloxacin, or moxifloxacin in Taiwan.
    Chou HW; Wang JL; Chang CH; Lee JJ; Shau WY; Lai MS
    Clin Infect Dis; 2013 Oct; 57(7):971-80. PubMed ID: 23948133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Fluoroquinolones and the Risk of Uveitis.
    Sandhu HS; Brucker AJ; Ma L; VanderBeek BL
    JAMA Ophthalmol; 2016 Jan; 134(1):38-43. PubMed ID: 26512796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uveitis risk following oral fluoroquinolone therapy: a nested case-control Study.
    Forooghian F; Maberley D; Albiani DA; Kirker AW; Merkur AB; Etminan M
    Ocul Immunol Inflamm; 2013 Oct; 21(5):390-3. PubMed ID: 23876164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of acute liver injury associated with the use of moxifloxacin and other oral antimicrobials: a retrospective, population-based cohort study.
    Kaye JA; Castellsague J; Bui CL; Calingaert B; McQuay LJ; Riera-Guardia N; Saltus CW; Quinlan S; Holick CN; Wahl PM; Suzart K; Rothman KJ; Wallander MA; Perez-Gutthann S
    Pharmacotherapy; 2014; 34(4):336-49. PubMed ID: 24865821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.
    Chou HW; Wang JL; Chang CH; Lai CL; Lai MS; Chan KA
    Clin Infect Dis; 2015 Feb; 60(4):566-77. PubMed ID: 25409476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of oral ciprofloxacin, levofloxacin, ofloxacin and moxifloxacin with the risk of serious ventricular arrhythmia: a nationwide cohort study in Korea.
    Cho Y; Park HS
    BMJ Open; 2018 Sep; 8(9):e020974. PubMed ID: 30269062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of hepatotoxicity associated with fluoroquinolones: a national case-control safety study.
    Alshammari TM; Larrat EP; Morrill HJ; Caffrey AR; Quilliam BJ; LaPlante KL
    Am J Health Syst Pharm; 2014 Jan; 71(1):37-43. PubMed ID: 24352180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral fluoroquinolone use and risk of peripheral neuropathy: a pharmacoepidemiologic study.
    Etminan M; Brophy JM; Samii A
    Neurology; 2014 Sep; 83(14):1261-3. PubMed ID: 25150290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactions.
    Jones SC; Budnitz DS; Sorbello A; Mehta H
    Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1099-106. PubMed ID: 23963962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between oral fluoroquinolone use and retinal detachment.
    Pasternak B; Svanström H; Melbye M; Hviid A
    JAMA; 2013 Nov; 310(20):2184-90. PubMed ID: 24281462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between recent use of fluoroquinolones and rhegmatogenous retinal detachment: a population-based cohort study.
    Kuo SC; Chen YT; Lee YT; Fan NW; Chen SJ; Li SY; Liu CJ; Chen TL; Chen TJ; Fung CP
    Clin Infect Dis; 2014 Jan; 58(2):197-203. PubMed ID: 24170197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient gatifloxacin therapy and dysglycemia in older adults.
    Park-Wyllie LY; Juurlink DN; Kopp A; Shah BR; Stukel TA; Stumpo C; Dresser L; Low DE; Mamdani MM
    N Engl J Med; 2006 Mar; 354(13):1352-61. PubMed ID: 16510739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.
    Iannini PB
    Curr Med Res Opin; 2007 Jun; 23(6):1403-13. PubMed ID: 17559736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Peripheral Neuropathy and Exposure to Oral Fluoroquinolone or Amoxicillin-Clavulanate Therapy.
    Morales D; Pacurariu A; Slattery J; Pinheiro L; McGettigan P; Kurz X
    JAMA Neurol; 2019 Jul; 76(7):827-833. PubMed ID: 31034074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
    J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral uveitis associated with fluoroquinolone therapy.
    Hinkle DM; Dacey MS; Mandelcorn E; Kalyani P; Mauro J; Bates JH; Soukasian SH; Holland GN; Foster CS; Fraunfelder FT; Davis JL; Fraunfelder FW
    Cutan Ocul Toxicol; 2012 Jun; 31(2):111-6. PubMed ID: 21981449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-agent, broad-spectrum fluoroquinolones for the outpatient treatment of low-risk febrile neutropenia.
    Cooper MR; Durand CR; Beaulac MT; Steinberg M
    Ann Pharmacother; 2011 Sep; 45(9):1094-102. PubMed ID: 21862714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral fluoroquinolones and risk of glaucoma.
    Yang L; Etminan M; Mikelberg FS
    J Glaucoma; 2014 Sep; 23(7):464-6. PubMed ID: 23632400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study.
    Paterson JM; Mamdani MM; Manno M; Juurlink DN;
    CMAJ; 2012 Oct; 184(14):1565-70. PubMed ID: 22891208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.